Roche recently launched the AVENIO Edge System to advance next-generation sequencing (NGS) technologies.
Researchers can use the pre-analytical program for sequencing library preparation, target...
Moderna and Carnegie Mellon University (CMU) recently launched its Artificial Intelligence (AI) Academy to bring mRNA therapies to patients.
The initiative will bring an immersive learning experience...
Roche and TIB Molbiol recently added three additional research use only test kits to detect mutations present in the Omicron COVID-19 variant.
The three test kits, VirSNip SARS Spike ins214EPE,...
GSK recently launched an international, multi-year initiative to advance innovation and address key needs in the multiple myeloma community.
The project, Target the Future, will provide education on...
CVS Health recently announced several initiatives to boost affordable healthcare and increase access to medicine for customers.
First, the company named Prem Shah to the newly created role of...
Pfizer and Amazon Web Services (AWS) recently collaborated to create innovative, cloud-based solutions to improve drug development, manufacturing, and distribution for clinical trials.
The...
FDA is working with federal partners and regulators to address potential impacts of the new Omicron variant and urges everyone to receive COVID-19 vaccinations or booster shots, according to an...
Novo Nordisk recently entered into a pharma acquisition deal with Dicerna Pharmaceuticals to increase its pipeline of RNAi therapies and technology platforms.
Dicerna develops RNAi-based...
Johnson & Johnson recently announced that it will evaluate its COVID-19 vaccine against the new and rapidly spreading Omicron variant.
Specifically, Johnson & Johnson is testing blood...
FDA recently approved Voxzogo injection for children five years of age and older with achondroplasia and open epiphyses.
Achondroplasia is the most common form of dwarfism. Individuals living...
FDA recently granted breakthrough device designation for Datar Cancer Genetics’ blood test to detect early-stage breast cancer.
The test, TriNetra, uses proprietary technology to detect...
Pfizer, BioNTech, and instant logistics company, Zipline, collaborated to deliver authorized mRNA COVID-19 vaccines requiring ultra-cold-chain in Ghana.
The companies recently developed and...
Moderna and Metagenomi recently entered into a strategic research and development collaboration to advance new gene editing systems for in vivo human therapeutic applications.
Under the terms of the...
FDA recently approved Novartis’ Scemblix to treat chronic myeloid leukemia (CML) for adult and pediatric patients with Philadelphia chromosome-positive CML in chronic phase.
Scemblix is the...
The US government recently purchased additional doses of Eli Lilly and Company’s combination COVID-19 antibody treatment.
Under the agreement, Eli Lilly and Company will supply 614,000 doses of...
Moderna recently dosed the first participant in the Phase 3 pivotal registration study of its cytomegalovirus (CMV) mRNA vaccine candidate, mRNA-1647.
The CMVictory study will evaluate the safety and...
Novartis and Global Heart Hub recently launched Invisible Nation, a program to bring together a global network of patient organizations and other stakeholders to tackle atherosclerotic cardiovascular...
Roche recently launched the AVENIO Tumor Tissue CGP Kit, a genomic profiling kit to allow laboratories to expand their oncology research in-house.
AVENIO Tumor Tissue CGP Kit is a...
FDA recently granted emergency use authorization to Thermo Fisher Scientific to run new saliva sample collection methods on its COVID-19 tests.
The company’s molecular diagnostics Spectrum...
